摘要
目的:探讨急诊应用胺碘酮治疗顽固性室性心动过速的临床疗效。方法:对45例顽固性室性心动过速患者急诊应用胺碘酮治疗,观察转复疗效、胺碘酮用量及不良反应。结果:转复率为95.6%(43/45);胺碘酮静脉用量为1450~2200mg,平均(1750.5±120.0)mg;胺碘酮口服用量为120~600mg,平均(250.0±51.5)mg;2例患者出现血压下降,1例患者出现恶心、食欲差,2例患者出现心动过缓(<50次/min),不良反应发生率为11.1%(5/45);用药后LVEF均较用药前有显著改善(P<0.05),而HR、SBP、DBP、QTc、QTcd均无明显变化(P>0.05)。结论:胺碘酮能安全、快速而有效控制顽固性室性心动过速。
Objective:To investigate the clinical efficacy of the emergency application of amiodarone treatment of refractory ventricular tachycardia.Methods:45 cases of patients with refractory ventricular tachycardia emergency amiodarone treatment,observation cardioversion efficacy of amiodarone dosage and adverse reactions.Results:After transfection complex was 95.6%(43/45);amiodarone intravenous dosage of 1450 ~ 2200mg(1750.5 ± 120.0) mg;120 ~ 600mg the Amiodarone oral dosage,the average(250.0±51.5) mg;drop in blood pressure in 2 patients,1 patient with nausea,poor appetite,two cases of patients with bradycardia(50 times/min),the incidence of adverse reactions was 11.1%(5/45);LVEF compared with medication after treatment before there were significant improvements(P0.05),while the HR SBP and DBP,QTc and QTcd no obvious change(P0.05).Conclusion: Amiodarone safe,fast and effective control of refractory ventricular tachycardia.
出处
《中国医药导刊》
2012年第10期1769-1770,共2页
Chinese Journal of Medicinal Guide
关键词
胺碘酮
顽固性室性心动过速
剂量
Amiodarone
Refractory Ventricular Tachycardia
Dose